did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9781585624027

Managing the Side Effects of Psychotropic Medications

by ; ;
  • ISBN13:

    9781585624027

  • ISBN10:

    1585624020

  • Edition: 1st
  • Format: Paperback
  • Copyright: 2012-04-05
  • Publisher: Amer Psychiatric Pub Inc

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $77.00 Save up to $19.25
  • Buy Used
    $57.75
    Add to Cart Free Shipping Icon Free Shipping

    USUALLY SHIPS IN 2-4 BUSINESS DAYS

Supplemental Materials

What is included with this book?

Summary

Managing the Side Effects of Psychotropic Medicationsprovides comprehensive, pragmatic information on anticipating and countering adverse drug effects when they occur. Cowritten by a research psychopharmacologist and a consultation-liaison psychiatrist, this book fills a void in the literature, helping mental health practitioners assess the risks and benefits of specific psychotropic medications and undertake strategies for managing adverse effects. This volume includes a wealth of information relevant to clinical psychiatrists, psychiatric residents, and psychiatric nurses, as well as medical students engaged in a psychiatry rotation. Highlights include: A review of fundamental concepts from internal medicine relevant to psychopharmacology across all major organ systems affected by antidepressants, antipsychotics, mood stabilizers, stimulants, sedative-hypnotics, and other major psychotropic classes Practical discussion of the strengths and weaknesses of viable antidote strategies for common adverse drug effects, including weight gain, metabolic dysregulation, sexual dysfunction, sleep disorders, skin rashes, movement disorders, and cognitive disturbances. Readers will understand the scientific rationale and evidence base behind available methods to counteract adverse drug effects An entire section on vulnerable populations, including children, the medically ill, and older adults, including the special considerations in prescribing and intervening when adverse effects arise Guidance for managing emergency situations, beginning with how to determine whether such a situation-e.g., allergic reaction or overdose-exists. Easy-to-use tables provide critical information needed to respond rapidly and appropriately to emergency situations including overdoses, neurotoxicities, and systemic reactions A 25-question, multiple-choice self-assessment that employs a combination of case studies and straightforward questions on mechanisms of action, key symptoms, and medication selection, providing the reader with an effective way to measure learning A series of appendices that distill complex information into readily-comprehensible form on vital topics including commonly reported adverse effects, common psychotropic drug interactions, resources for practitioners, and rating scales for measuring adverse drug effects. Most valuable of all, Managing the Side Effects of Psychotropic Medications provides concise, bottom-line summary recommendations that synthesize all available empirical and anecdotal information on psychotropic medications. Mental health practitioners will appreciate its comprehensiveness and wise counsel.

Table of Contents

Forewordp. xv
Prefacep. xvii
Introductionp. xxiii
List of Abbreviationsp. xxvii
List of Drugsp. xxix
General Considerations
The Psychiatrist as Physicianp. 3
Primary Care Psychiatryp. 3
Differentiating Adverse Drug Effects From Primary Illness Symptomsp. 7
The Nocebo Phenomenon and Proneness to Adverse Effectsp. 16
Negative Therapeutic Reactionsp. 20
Attribution and Causalityp. 21
Paradoxical Adverse Effectsp. 23
Extrapolating "Evidence-Based Research Findings" to "Real-World" Patientsp. 26
Dose Relationships and Adverse Effectsp. 28
FDA Warnings and Precautionsp. 32
Risk-Benefit Analysesp. 33
General Approach to Assessing Adverse Drug Effectsp. 43
Pharmacokinetics, Pharmacodynamics, and Pharmacogenomicsp. 47
Pharmacokinetics and Pharmacodynamicsp. 47
Toxic Polypharmacyp. 57
Gender and Racial Differences in Adverse Effectsp. 57
Alcoholp. 60
Brand Versus Generic Formulationsp. 60
Enantiomeric Versus Racemic Agents, and Parent Versus Metabolite Compoundsp. 61
Drug Blood Levelsp. 62
Pharmacogenomic Predictors of Adverse Effectsp. 63
Vulnerable Populationsp. 71
Patients' Diverse Proneness to Drug Side Effectsp. 71
Childrenp. 72
Medically III Patientsp. 73
Older Adultsp. 75
Patients Prone to Somatizationp. 75
Adverse Psychiatric Effects of Nonpsychotropic Medicationsp. 83
Analgesicsp. 84
Anticholinergicsp. 85
Anticonvulsantsp. 85
Antimicrobialsp. 85
Antineoplasticsp. 86
Antiparkinsonian Agentsp. 87
Antiretroviral Agentsp. 87
Cardiovascular Drugsp. 89
Dermatological Agentsp. 90
Gastrointestinal Agentsp. 91
Immunosuppressantsp. 91
Interferon-¿p. 92
Oral Contraceptives and Intravaginal Ringsp. 93
Smoking Cessation Aidsp. 95
Steroidsp. 95
Adverse Psychiatric Effects of Psychiatric Medicationsp. 97
Activation and Mania/Hypomania or Mixed Statesp. 97
Anxiety and Panicp. 100
Clinical Trial Subjects With Psychiatric Illnessp. 100
Discontinuation Phenomenap. 101
Disinhibition and Impaired Impulse Controlp. 101
Emotional Dullingp. 101
Psychosisp. 102
Suicidal Thinking or Behaviorp. 103
What Nonmedical Therapists Should Know About Adverse Drug Effectsp. 105
Organ Systems
Cardiovascular Systemp. 113
Arrhythmias and Palpitationsp. 113
Cerebrovascular Accidentsp. 122
Dyslipidemiasp. 123
Edemap. 129
Hypertensionp. 137
Myocarditis and Cardiomyopathyp. 139
Orthostatic Hypotensionp. 140
Dermatological Systemp. 141
Alopeciap. 141
Hyperhidrosisp. 142
Photosensitivityp. 143
Pruritusp. 144
Skin Rashesp. 145
Ear, Nose, and Throatp. 155
Bruxisp. 155
Dysarthriap. 156
Dysgeusiap. 157
Oral Lesionsp. 158
Sialorrheap. 159
Stomatodynia (Burning Mouth Syndrome)p. 161
Xerostomiap. 162
Electrolyte Abnormalitiesp. 163
Hyponatremia and SIADHp. 163
Metabolic Acidosis and Alkalosisp. 166
Endocrinopathiesp. 169
Bone Demineralization and Osteoporosisp. 169
Glycemic Dysregulation and Diabetes Mellitusp. 170
Hyperprolactinemia, Galactorrhea, and Gynecomastiap. 175
Menstrual Disturbances and Polycystic Ovary Syndromep. 178
Parathyroid Abnormalitiesp. 179
Thyroid Abnormalitiesp. 185
Gastrointestinal Systemp. 187
Diarrhea, Hypermotility, and Constipationp. 187
Gastrointestinal Bleedingp. 188
Hepatic Impairment and Transaminitisp. 189
Hyperammonemiap. 191
Malabsorption Disordersp. 196
Nausea and Gastrointestinal Upsetp. 197
Pancreatitisp. 198
Genitourinary and Renal Systemsp. 201
Dysuria and Urinary Retentionp. 201
Enuresis and Urinary Incontinencep. 202
Nephrotic Syndromep. 203
Nephrotoxicity and Nephrogenic Diabetes Insipidusp. 203
Priapismp. 206
Renal Calculip. 207
Renal Insufficiencyp. 208
Sexual Dysfunctionp. 209
Hematological Systemp. 231
Myelosuppression: Agranulocytosis and Thrombocytopeniap. 231
Platelet Aggregation Disorders and Bleeding Riskp. 235
Red Blood Cellsp. 236
Musculoskeletal Systemp. 239
Joint Painp. 239
Leg Crampsp. 240
Myalgiasp. 241
Neurological Systemp. 243
Akathisia and Extrapyramidal Adverse Effectsp. 243
Cognitive Complaintsp. 245
Delirium and Encephalopathyp. 247
Dyskinesias and Dystoniasp. 250
Fatigue and Sedationp. 256
Headachep. 257
Motor Ticsp. 260
Muscle Twitching, Fasciculations, and Myoclonusp. 261
Nystagmusp. 264
Oculogyric Crisesp. 265
Paresthesias and Neuropathiesp. 266
Seizuresp. 267
Tinnitusp. 268
Tremorp. 268
Yawningp. 270
Ophthalmological Systemp. 273
Cataractsp. 273
Diplopia/Blurred Visionp. 274
Glaucomap. 274
Retinopathiesp. 275
Sleep Disturbancesp. 277
Hypersomnia and Sleep Attacksp. 277
Insomniap. 278
Nightmares and Vivid Dreamsp. 285
Parasomniasp. 286
Systemic Reactionsp. 289
Allergic Reactions and Angioedemap. 289
Antiepileptic Hypersensitivity Reactionsp. 290
Body Temperature Dysregulationp. 291
Discontinuation Syndromesp. 291
Drug-Induced Lupus Erythematosusp. 293
Neuroleptic Malignant Syndromep. 294
Serotonin Syndromep. 295
Weight Gainp. 296
Weight Lossp. 326
Pregnancy and the Puerperiump. 331
Breast-Feeding and Adverse Eventsp. 332
Growth Effectsp. 332
Teratogenicityp. 332
Withdrawal in the Newbornp. 335
Emergency Situationsp. 339
Summary Recommendations
Summary Recommendationsp. 359
The Futurep. 362
Self-Assessment Questions and Answersp. 363
Resources for Practitionersp. 381
p. 397
p. 425
Table of Contents provided by Ingram. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program